
Publications of M. Groll
All genres
Journal Article (28)
1.
Journal Article
51 (1), pp. 247 - 249 (2012)
Hydroxyureas as Noncovalent Proteasome Inhibitors. Angewandte Chemie-International Edition 2.
Journal Article
50 (2), pp. 542 - 544 (2011)
Elucidation of the alpha-Keto-Aldehyde Binding Mechanism: A Lead Structure Motif for Proteasome Inhibition. Angewandte Chemie-International Edition 3.
Journal Article
5 (10), pp. 1701 - 1705 (2010)
20S Proteasome Inhibition: Designing Noncovalent Linear Peptide Mimics of the Natural Product TMC-95A. ChemMedChem 4.
Journal Article
Convergent Synthesis and Biological Evaluation of Syringolin A and Derivatives as Eukaryotic 20S Proteasome Inhibitors. European Journal of Organic Chemistry (21), pp. 3991 - 4003 (2010)
5.
Journal Article
5, pp. 1701 - 1705 (2010)
20S Proteasome Inhibition: Designing Noncovalent Linear Peptide Mimics of the Natural Product TMC-95A. ChemMedChem 6.
Journal Article
10 (16), pp. 2638 - 2643 (2009)
Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapted Leukaemic Cell Lines. ChemBioChem 7.
Journal Article
106 (16), pp. 6507 - 6512 (2009)
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition. Proceedings of the National Academy of Sciences of the United States of America 8.
Journal Article
15 (2), pp. 58 - 66 (2009)
The persisting challenge of selective and specific proteasome inhibition. Journal of Peptide Science 9.
Journal Article
452 (7188), pp. 755 - 758 (2008)
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism. NATURE 10.
Journal Article
235, p. 24-MEDI (2008)
MEDI 24-Macrocyclic peptidyl biaryl-ether inhibitors provide evidence for the catalytic versatility of the 20S proteasome. Abstracts of Papers of the American Chemical Society 11.
Journal Article
13 (6), pp. 607 - 614 (2006)
TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome. Chemistry & Biology 12.
Journal Article
128 (15), pp. 5136 - 5141 (2006)
Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding. Journal of the American Chemical Society 13.
Journal Article
103 (12), pp. 4576 - 4579 (2006)
Inhibitor-binding mode of homobelactosin C to proteasomes: New insights into class I MHC ligand generation. Proceedings of the National Academy of Sciences of the United States of America 14.
Journal Article
280 (39), pp. 33387 - 33396 (2005)
X-ray snapshots of peptide processing in mutants of tricorn-interacting factor F1 from Thermoplasma acidophilum. Journal of Biological Chemistry 15.
Journal Article
6 (2), pp. 222 - 256 (2005)
Molecular machines for protein degradation. ChemBioChem 16.
Journal Article
398, pp. 329 - 336 (2005)
Purification, crystallization, and x-ray analysis of the yeast 20S proteasome. Methods in Enzymology 17.
Journal Article
1695 (1-3), pp. 33 - 44 (2004)
Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Biochimica et Biophysica Acta-Molecular Cell Research 18.
Journal Article
5 (9), pp. 1256 - 1266 (2004)
Binding mode of TMC-95A analogues to eukaryotic 20S proteasome. ChemBioChem 19.
Journal Article
1 (1), pp. 161 - 173 (2004)
TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors. Chemistry & Biodiversity 20.
Journal Article
5 (19), pp. 3435 - 3437 (2003)
Synthesis of a TMC-95A ketomethylene analogue by cyclization via intramolecular Suzuki coupling. Organic Letters